60,000FU/g Nattokinase, equal to 1000 x 6,000FU doses.
Introduction
Nattokinase (NK) is the primary ingredient of nattō, a traditional Asian food made from fermented soybean by Bacillus subtilis natto. Studies have shown that nattō reduces the risk of cardiovascular disease (CVD) mortality due to its fibrinolytic and antithrombotic properties. A new field of studies also demonstrates that NK can mitigate molecular pathways related to inflammation and oxidative stress and can be considered an adjuvant strategy for use in many non-communicable diseases (NCDs).
Our NK is manufactured by Global leaders Contek Life Science Co in Taiwan. Contek specialise in the production of NK and have removed the Vitamin K2.
Strength
Fibrinolytic Units (FU) refer to a measure of the activity of enzymes, particularly those found in certain medications or naturally occurring substances, that break down fibrin, the protein that forms the meshwork of blood clots.
These enzymes are called fibrinolytic enzymes or thrombolytics. Essentially, FU quantifies how effectively these substances can dissolve blood clots, thus restoring normal blood flow.
In powder form, 60,000 FU/g with maltodextrin as the excipient.
Studies
Nattokinase as an adjuvant therapeutic strategy for non-communicable diseases: a review of fibrinolytic, antithrombotic, anti-inflammatory, and antioxidant effects https://pubmed.ncbi.nlm.nih.gov/39404094/
Effect of Nattokinase in D-galactose- and Aluminum Chloride-induced Alzheimer’s Disease Model of Rat https://pubmed.ncbi.nlm.nih.gov/39477413/
Research Progress of Nattokinase in Reducing Blood Lipid https://pubmed.ncbi.nlm.nih.gov/40507053/
Degradative Effect of Nattokinase on Spike Protein
of SARS-CoV-2 https://pubmed.ncbi.nlm.nih.gov/36080170/
